Literature DB >> 24703445

Current techniques in the management of cervical myelopathy and radiculopathy.

Carter S Gerard1, John E O'Toole2.   

Abstract

Posterior decompressive procedures are a fundamental component of the surgical treatment of symptomatic cervical degenerative disease. Posterior approaches have the appeal of avoiding complications associated with anterior approaches such as esophageal injury, recurrent laryngeal nerve paralysis, dysphagia, and adjacent-level disease after fusion. Although open procedures are effective, the extensive subperiosteal stripping of the paraspinal musculature leads to increased blood loss, longer hospital stays, and more postoperative pain, and potentially contributes to instability. Minimally invasive access has been developed to limit approach-related morbidity. This article reviews current techniques in minimally invasive surgical management of cervical myelopathy and radiculopathy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical; Foraminotomy; Minimally invasive; Posterior

Mesh:

Year:  2014        PMID: 24703445     DOI: 10.1016/j.nec.2013.12.005

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

1.  Role of posterior elements in the disc bulging of a degenerated cervical spine.

Authors:  Farid Amirouche; Giovanni F Solitro; Kris Siemionow; David Drucker; Ashish Upadhyay; Priyesh Patel
Journal:  Int J Spine Surg       Date:  2015-05-02

2.  Minimally Invasive Posterior Cervical Foraminotomy Versus Anterior Cervical Fusion and Arthroplasty: Systematic Review and Meta-Analysis.

Authors:  Andrew Platt; Richard G Fessler; Vincent C Traynelis; John E O'Toole
Journal:  Global Spine J       Date:  2021-12-08

3.  The incidence of cervical spondylosis decreases with aging in the elderly, and increases with aging in the young and adult population: a hospital-based clinical analysis.

Authors:  Chuanling Wang; Fuming Tian; Yingjun Zhou; Wenbo He; Zhiyou Cai
Journal:  Clin Interv Aging       Date:  2016-01-12       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.